Literature DB >> 6870822

Use of procainamide gels in the purification of human and horse serum cholinesterases.

J S Ralston, A R Main, B F Kilpatrick, A L Chasson.   

Abstract

Two large-scale methods based primarily on the use of procainamide-Sepharose gels were developed for the purification of horse and human serum non-specific cholinesterases. With method I, the procainamide-Sepharose 4B gel was used in the first step to handle large volumes of serum. With method II, the procainamide-Sepharose 4B gel was used in the final step to obtain pure enzyme. Although both methods gave electrophoretically pure cholinesterase preparations in good yields, they were significantly more efficient at purifying the horse enzyme than the human enzyme. To study this problem, the relative binding of human and horse cholinesterases to procainamide-, methylacridinium (MAC)-, m-trimethylammoniophenyl (m-PTA)- and p-trimethylammoniophenyl (p-PTA)-Sepharose 4B gels were measured, by using two approaches. In one, binding was measured by a procedure involving equilibration of pure cholinesterase in a small volume of diluted gel slurry (4%, v/v). A partially purified preparation of Electrophorus acetylcholinesterase was included. Pure human cholinesterase bound consistently more tightly to each of the gels than did horse cholinesterase, and the acetylcholinesterase appeared to bind the gels 10-100 times more tightly than did the non-specific cholinesterases. The order of binding for the cholinesterases, beginning with the tightest, was: procainamide-Sepharose 4B, MAC-Sepharose 4B, p-PTA-Sepharose 4B and m-PTA-Sepharose 4B. For the acetylcholinesterase the order was: MAC-Sepharose 4B, procainamide-Sepharose 4B, p-PTA-Sepharose 4B and m-PTA-Sepharose 4B. The second approach involved passing native sera or partially purified sera fractions through 1 ml test columns of each of the four affinity gels to determine their retention capacity for the cholinesterases. With these impure samples, the MAC-Sepharose 4B gels proved superior to the procainamide-Sepharose 4B gels at retaining human cholinesterase, but the opposite was true for the horse cholinesterase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6870822      PMCID: PMC1154348          DOI: 10.1042/bj2110243

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  Affinity chromatography of acetylcholinesterase.

Authors:  Y Dudai; I Silman
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

2.  Purification of acetylcholinesterase by affinity chromatography and determination of active site stoichiometry.

Authors:  T L Rosenberry; H W Chang; Y T Chen
Journal:  J Biol Chem       Date:  1972-03-10       Impact factor: 5.157

3.  A method for the purification of acetylcholinesterase by affinity chromatography.

Authors:  N Kalderon; I Silman; S Blumberg; Y Dudai
Journal:  Biochim Biophys Acta       Date:  1970-06-23

4.  Purification of horse serum cholinesterase by preparative polyacrylamide gel electrophoresis.

Authors:  A R Main; E Tarkan; J L Aull; W G Soucie
Journal:  J Biol Chem       Date:  1972-01-25       Impact factor: 5.157

5.  [Isolation and physico-chemical characterization of cholinesterase in human serum].

Authors:  H Haupt; K Heide; O Zwisler; H G Schwick
Journal:  Blut       Date:  1966-11

6.  Human-serum cholinesterase subunits and number of active sites of the major component.

Authors:  H Muensch; H W Goedde; A Yoshida
Journal:  Eur J Biochem       Date:  1976-11-01

7.  Purification by affinity chromatography of the molecular forms of acetylcholinesterase present in fresh electric-organ tissue of electric eel.

Authors:  Y Dudai; I Silman; M Shinitzky; S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

8.  The purification of cholinesterase from horse serum.

Authors:  A R Main; W G Soucie; I L Buxton; E Arinc
Journal:  Biochem J       Date:  1974-12       Impact factor: 3.857

9.  Purification and properties of human serum cholinesterase.

Authors:  P K Das; J Liddell
Journal:  Biochem J       Date:  1970-03       Impact factor: 3.857

10.  Purification by affinity chromatography of acetylcholinesterase from electric organ tissue of the electric eel subsequent to tryptic treatment.

Authors:  Y Dudai; I Silman; N Kalderon; S Blumberg
Journal:  Biochim Biophys Acta       Date:  1972-04-07
View more
  15 in total

1.  Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine.

Authors:  Max Zhan; Shurong Hou; Chang-Guo Zhan; Fang Zheng
Journal:  Biochem J       Date:  2014-01-01       Impact factor: 3.857

2.  His-tag truncated butyrylcholinesterase as a useful construct for in vitro characterization of wild-type and variant butyrylcholinesterases.

Authors:  Erik C Ralph; Longkuan Xiang; John R Cashman; Jun Zhang
Journal:  Protein Expr Purif       Date:  2011-07-23       Impact factor: 1.650

3.  Characterization of butyrylcholinesterase in bovine serum.

Authors:  Alicia J Dafferner; Sofya Lushchekina; Patrick Masson; Gaoping Xiao; Lawrence M Schopfer; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2017-02-08       Impact factor: 5.192

Review 4.  Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs.

Authors:  Yvonne Rosenberg; Ashima Saxena
Journal:  Neuropharmacology       Date:  2020-05-19       Impact factor: 5.250

5.  Development of an immunoassay for avian serum butyrylcholinesterase and its use in assessing exposure to organophosphorus and carbamate pesticides.

Authors:  H M Thompson
Journal:  Bull Environ Contam Toxicol       Date:  1995-02       Impact factor: 2.151

6.  LARGE SCALE PURIFICATION OF BUTYRYLCHOLINESTERASE FROM HUMAN PLASMA SUITABLE FOR INJECTION INTO MONKEYS; A POTENTIAL NEW THERAPEUTIC FOR PROTECTION AGAINST COCAINE AND NERVE AGENT TOXICITY.

Authors:  Oksana Lockridge; Lawrence M Schopfer; Gail Winger; James H Woods
Journal:  J Med Chem Biol Radiol Def       Date:  2005-07-01

Review 7.  Identification and characterization of biomarkers of organophosphorus exposures in humans.

Authors:  Jerry H Kim; Richard C Stevens; Michael J MacCoss; David R Goodlett; Alex Scherl; Rebecca J Richter; Stephanie M Suzuki; Clement E Furlong
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

8.  Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.

Authors:  Zrinka Kovarik; Zoran Radić; Harvey A Berman; Vera Simeon-Rudolf; Elsa Reiner; Palmer Taylor
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

9.  The proline-rich tetramerization peptides in equine serum butyrylcholinesterase.

Authors:  Kevser Biberoglu; Lawrence M Schopfer; Ozden Tacal; Oksana Lockridge
Journal:  FEBS J       Date:  2012-09-07       Impact factor: 5.542

10.  Kinetic characterization of human butyrylcholinesterase mutants for the hydrolysis of cocaethylene.

Authors:  Shurong Hou; Max Zhan; Xirong Zheng; Chang-Guo Zhan; Fang Zheng
Journal:  Biochem J       Date:  2014-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.